Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Doctors Lax in Monitoring Potentially Addicting Drugs

By HospiMedica International staff writers
Posted on 14 Mar 2011
A new study claims that few primary care physicians pay adequate attention to patients taking prescription opioid drugs for chronic noncancer pain (CNCP), despite the potential for abuse, addiction, and overdose.

Researchers at Yeshiva University (YU; New York, NY, USA) conducted a retrospective cohort study using electronic medical records (EMRs) of 1,612 patients on long-term opioids treated for CNCP in eight primary care practices. More...
The researchers examined three risk reduction strategies: urine drug tests; regular office visits (at least once per 6 months and within 30 days of modifying opioid treatment); and restricted early refills (one or fewer opioid refills more than a week early). Associations of risk factors with each outcome were assessed in mixed-effects models, adjusting for patient clustering within physicians, demographics, and clinical factors.

The results showed that only a small minority (8%) of patients were found to have undergone any urine drug testing. While such testing was more common in patients at higher risk for opioid misuse, the rate of testing among those high-risk patients was still low (24%). Only half of the patients were seen regularly in the office, and patients at higher risk of opioid misuse were not seen more frequently than patients at lower risk were. Although only 23% of all patients received two or more early opioid refills, patients at greater risk for opioid misuse were more likely to receive multiple early refills. An increasing number of risk factors was positively associated with urine drug testing, but negatively associated with restricted early refills. The study was published in the March 2, 2011, online edition of the Journal of General Internal Medicine.

"We were disturbed to find that patients with a drug use disorder were seen less frequently in the office and were prescribed more early refills than patients without these disorders,” said lead author Joanna Starrels, MD, MS, an assistant professor of medicine at the YU Albert Einstein College of Medicine. "The finding that physicians did not increase precautions for patients at highest risk for opioid misuse should be a call for a standardized approach to monitoring.”

Prescription drug misuse is a major public health problem. An estimated 48 million people over the age of 12 in the United States have taken prescription drugs for nonmedical uses in their lifetime, which represents approximately 20% of the US population. Opioids, central nervous system depressants, and stimulants were the drugs most commonly abused.

Related Links:

Yeshiva University




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.